Recent Finacing
Recent Raise
GoLiver Therapeutics develops an injectable allogeneic frozen hepatocyte therapy derived from pluripotent stem cells, scaling biomanufacturing in France to produce clinical batches for Phase I/IIa trials with hospital partnership.
